Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-10

Clinical Trial Update: The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)

View source ↗

Summary

Completed clinical validation of fractionated exhaled nitric oxide for diagnosing and assessing disease activity in eosinophilic esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Eosinophilic Esophagitis | Status: COMPLETED